Fredric N. Eshelman - Mar 29, 2022 Form 4 Insider Report for Aravive, Inc. (ARAV)

Role: Executive Chairman of Board, Director, 10%+ Owner
Signature: /s/ ESHELMAN VENTURES, LLC, By: /s/ Fredric N. Eshelman, Name: Fredric N. Eshelman, Title: Managing Member
Stock symbol: ARAV
Transactions as of: Mar 29, 2022
Transactions value $: $3,892,477
Form type: 4
Date filed: 3/31/2022, 04:06 PM
Previous filing: Jan 5, 2022
Next filing: Apr 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARAV	Common Stock	Award	$2M	+860K	+22.6%	$2.33	4.67M	Mar 29, 2022	See Footnote 1	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARAV	Warrant (right to buy)	Award	$1.89M	+860K		$2.20	860K	Mar 29, 2022	Common Stock	860K	$2.20	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of common stock and Warrant to purchase shares of common stock of Aravive, Inc. (the "Company") are owned directly by Eshelman Ventures, LLC, an entity wholly owned by the Reporting Person. The Reporting Person, Dr. Fredric Eshelman, who is the Executive Chairman of the Company's Board of Directors, disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F2	The Warrant will be exercisable immediately and will expire on the five-year anniversary of the date of issuance; however, the Warrants will not be exercisable until the occurrence of certain events and will expire on the five- year anniversary of the date of exercisability.

Content

The shares of common stock and Warrant to purchase shares of common stock of Aravive, Inc. (the "Company") are owned directly by Eshelman Ventures, LLC, an entity wholly owned by the Reporting Person. The Reporting Person, Dr. Fredric Eshelman, who is the Executive Chairman of the Company's Board of Directors, disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

The Warrant will be exercisable immediately and will expire on the five-year anniversary of the date of issuance; however, the Warrants will not be exercisable until the occurrence of certain events and will expire on the five- year anniversary of the date of exercisability.